The Korean Journal of Blood Transfusion : eISSN 2383-6881 / pISSN 1226-9336

Table. 1.

Table. 1.

Clinical characteristics

Patients undergone TPE (N=95)P value
Age (years)53.3±8.90.099
Sex, male60 (63.2%)0.980
Body weight (kg)62.0±11.00.931
Prophylactic use of pheniramine82 (86.3%)0.647
Indication for TPE
 Desensitization, ABO-i LT56 (58.9%)0.089
 Hyperbilirubinemia26 (27.4%)0.214
 Others13 (13.7%)Reference
Type of replacement fluid0.691
 FFP only21 (22.1%)
 Albumin only4 (4.2%)
 FFP and Albumin70 (73.7%)
Amount of FFP (mL/kg)34.2±16.40.085
Amount of albumin (mL/kg)24.1±17.10.077
White blood cell count (×109/L)7.1±5.9
Hemoglobin (g/dL)11.1±2.5
Hematocrit (%)32.9±7.5
Platelet count (×109/L)94.7±59.7
Prothrombin time (sec)17.5±4.3
Serum albumin (g/dL)3.3±0.6
Serum creatinine (mg/dL)1.2±1.0

Data are presented as the mean±SD or N (%). P values were estimated by univariate logistic regression analysis. Variables with P<0.2 were adapted to multivariate analysis. Abbreviations: TPE, therapeutic plasma exchange; ABO-i LT, ABO-incompatible liver transplantation; FFP, fresh frozen plasma.

Korean J Blood Transfus 2019;30:148-55
© 2019 Korean J Blood Transfus